SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* TOBIN SCOTT R (Last) (First) (Middle) C/O BATTERY VENTURES 930 WINTER STREET SUITE 2500 (Street) WALTHAM MA 02451 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 06/27/2011	3. Issuer Name and Ticker or Trading Symbol CHAMPIONS ONCOLOGY, INC. [ CSBR.OB ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	8,566,667	I	By Funds(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant to purchase shares of Common Stock	04/04/2011	04/04/2016	Common Stock	820,000(2)	$0.9	I	By Funds(3)

Explanation of Responses:

1. Consists of 8,481,857 shares of the Issuer's Common Stock held by Battery Ventures IX, L.P. ("BVIX") and 84,810 shares of the Issuer's Common Stock held by Battery Investment Partners IX, LLC ("BIPIX"). BVIX and BIPIX are under common control, as Battery Partners IX, LLC ("BPIX") is the sole general partner of BVIX and the sole manager of BIPIX. BVIX, BIPIX and BPIX expressly disclaim beneficial ownership over all shares held by BVIX, BIPIX and BPIX, except to the extent of their indirect pecuniary interest therein.

2. The number of shares of common stock issuable upon the exercise of the warrant is subject to certain adjustments for dividends, combinations of stock, reorganizations or mergers or similar transactions pursuant to the terms of the warrant.

3. Consists of a warrant to purchase 811,882 shares of the Issuer's Common Stock held by BVIX and a warrant to purchase 8,118 shares of the Issuer's Common Stock held by BIPIX. BVIX and BIPIX are under common control, as BPIX is the sole general partner of BVIX and the sole manager of BIPIX. BVIX, BIPIX and BPIX expressly disclaim beneficial ownership over all shares held by BVIX, BIPIX and BPIX, except to the extent of their indirect pecuniary interest therein.

	/s/ Scott R. Tobin By: Christopher Schiavo (acting as attorney-in-fact on behalf of Scott R. Tobin)	06/29/2011
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.